Novel formulations of oral bisphosphonates in the treatment of osteoporosis. (2022)

First Author: Fuggle N
Attributed to:  Programme 3: Early development and risk of adult musculoskeletal disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40520-022-02272-z

PubMed Identifier: 36331798

Publication URI: http://europepmc.org/abstract/MED/36331798

Type: Journal Article/Review

Volume: 34

Parent Publication: Aging clinical and experimental research

Issue: 11

ISSN: 1594-0667